PMC:7335697 / 0-2148
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 38-43 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
T2 | 179-184 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
T3 | 401-406 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
T4 | 529-534 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
T5 | 1636-1641 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
T6 | 1956-1961 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
T7 | 2143-2148 | Body_part | denotes | liver | http://purl.org/sig/ont/fma/fma7197 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 38-43 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T2 | 179-184 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T3 | 401-406 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T4 | 529-534 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T5 | 1636-1641 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T6 | 1956-1961 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T7 | 2143-2148 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 0-8 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 105-152 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 105-138 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T4 | 154-162 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 166-175 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 434-442 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 445-454 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T8 | 562-570 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 573-582 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T10 | 647-655 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 928-950 | Disease | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
T12 | 961-973 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T13 | 978-995 | Disease | denotes | diabetes mellitus | http://purl.obolibrary.org/obo/MONDO_0005015 |
T14 | 1331-1366 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T15 | 1337-1366 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T16 | 1566-1572 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T17 | 1665-1673 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T18 | 1816-1822 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T19 | 1999-2007 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T20 | 2026-2034 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 38-43 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T2 | 38-43 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
T3 | 82-91 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | Objective |
T4 | 179-184 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T5 | 179-184 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
T6 | 273-276 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | aim |
T7 | 380-381 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 401-406 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T9 | 401-406 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
T10 | 529-534 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T11 | 529-534 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
T12 | 824-828 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
T13 | 824-828 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
T14 | 952-960 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arterial |
T15 | 952-960 | http://www.ebi.ac.uk/efo/EFO_0000814 | denotes | arterial |
T16 | 1164-1166 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T17 | 1312-1314 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T18 | 1390-1391 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T19 | 1553-1554 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T20 | 1636-1641 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T21 | 1636-1641 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
T22 | 1803-1804 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T23 | 1956-1961 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T24 | 1956-1961 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
T25 | 2143-2148 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T26 | 2143-2148 | http://www.ebi.ac.uk/efo/EFO_0000887 | denotes | liver |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 824-828 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
T2 | 1112-1114 | Chemical | denotes | GI | http://purl.obolibrary.org/obo/CHEBI_73907 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 0-8 | Disease | denotes | COVID-19 | MESH:C000657245 |
6 | 105-152 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
7 | 154-164 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
8 | 166-175 | Disease | denotes | infection | MESH:D007239 |
9 | 434-454 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
12 | 562-582 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
13 | 647-655 | Disease | denotes | COVID-19 | MESH:C000657245 |
30 | 1112-1114 | Gene | denotes | GI | Gene:2770 |
31 | 796-804 | Species | denotes | patients | Tax:9606 |
32 | 911-919 | Species | denotes | patients | Tax:9606 |
33 | 1499-1507 | Species | denotes | patients | Tax:9606 |
34 | 1531-1539 | Species | denotes | patients | Tax:9606 |
35 | 928-950 | Disease | denotes | cardiovascular disease | MESH:D002318 |
36 | 952-973 | Disease | denotes | arterial hypertension | MESH:D000081029 |
37 | 978-995 | Disease | denotes | diabetes mellitus | MESH:D003920 |
38 | 1041-1046 | Disease | denotes | fever | MESH:D005334 |
39 | 1054-1059 | Disease | denotes | cough | MESH:D003371 |
40 | 1067-1075 | Disease | denotes | dyspnoea | MESH:D004417 |
41 | 1083-1090 | Disease | denotes | fatigue | MESH:D005221 |
42 | 1094-1101 | Disease | denotes | myalgia | MESH:D063806 |
43 | 1331-1366 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
44 | 1544-1548 | Disease | denotes | died | MESH:D003643 |
45 | 1566-1572 | Disease | denotes | cancer | MESH:D009369 |
49 | 1844-1852 | Species | denotes | patients | Tax:9606 |
50 | 1665-1673 | Disease | denotes | COVID-19 | MESH:C000657245 |
51 | 1816-1822 | Disease | denotes | cancer | MESH:D009369 |
54 | 1999-2009 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
55 | 1985-1993 | Disease | denotes | infected | MESH:D007239 |
58 | 2061-2069 | Species | denotes | patients | Tax:9606 |
59 | 2026-2034 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 928-950 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T2 | 961-973 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T3 | 978-995 | Phenotype | denotes | diabetes mellitus | http://purl.obolibrary.org/obo/HP_0000819 |
T4 | 1041-1046 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T5 | 1054-1059 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
T6 | 1067-1075 | Phenotype | denotes | dyspnoea | http://purl.obolibrary.org/obo/HP_0002094 |
T7 | 1083-1090 | Phenotype | denotes | fatigue | http://purl.obolibrary.org/obo/HP_0012378 |
T8 | 1094-1101 | Phenotype | denotes | myalgia | http://purl.obolibrary.org/obo/HP_0003326 |
T9 | 1337-1357 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T10 | 1566-1572 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
T11 | 1816-1822 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-71 | Sentence | denotes | COVID-19 in an international European liver transplant recipient cohort |
T2 | 73-81 | Sentence | denotes | Abstract |
T3 | 82-91 | Sentence | denotes | Objective |
T4 | 92-268 | Sentence | denotes | Knowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. |
T5 | 269-455 | Sentence | denotes | The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection. |
T6 | 457-463 | Sentence | denotes | Design |
T7 | 464-665 | Sentence | denotes | We conducted an international prospective study across Europe on liver transplant recipients with SARS-CoV-2 infection confirmed by microbiological assay during the first outbreak of COVID-19 pandemic. |
T8 | 666-783 | Sentence | denotes | Baseline characteristics, clinical presentation, management of immunosuppressive therapy and outcomes were collected. |
T9 | 785-792 | Sentence | denotes | Results |
T10 | 793-878 | Sentence | denotes | 57 patients were included (70% male, median (IQR) age at diagnosis 65 (57–70) years). |
T11 | 879-1010 | Sentence | denotes | 21 (37%), 32 (56%) and 21 (37%) patients had one cardiovascular disease, arterial hypertension and diabetes mellitus, respectively. |
T12 | 1011-1130 | Sentence | denotes | The most common symptoms were fever (79%), cough (55%), dyspnoea (46%), fatigue or myalgia (56%) and GI symptoms (33%). |
T13 | 1131-1211 | Sentence | denotes | Immunosuppression was reduced in 22 recipients (37%) and discontinued in 4 (7%). |
T14 | 1212-1264 | Sentence | denotes | With this regard, no impact on outcome was observed. |
T15 | 1265-1367 | Sentence | denotes | Forty-one (72%) subjects were hospitalised and 11 (19%) developed acute respiratory distress syndrome. |
T16 | 1368-1508 | Sentence | denotes | Overall, we estimated a case fatality rate of 12% (95% CI 5% to 24%), which increased to 17% (95% CI 7% to 32%) among hospitalised patients. |
T17 | 1509-1573 | Sentence | denotes | Five out of the seven patients who died had a history of cancer. |
T18 | 1575-1585 | Sentence | denotes | Conclusion |
T19 | 1586-1802 | Sentence | denotes | In this European multicentre prospective study of liver transplant recipients, COVID-19 was associated with an overall and in-hospital fatality rate of 12% (95% CI 5% to 24%) and 17% (95% CI 7% to 32%), respectively. |
T20 | 1803-1873 | Sentence | denotes | A history of cancer was more frequent in patients with poorer outcome. |
T21 | 1875-1901 | Sentence | denotes | Significance of this study |
T22 | 1903-1941 | Sentence | denotes | What is already known on this subject? |
T23 | 1942-2010 | Sentence | denotes | Recipients of liver transplantation can be infected with SARS-CoV-2. |
T24 | 2011-2088 | Sentence | denotes | The outcome of COVID-19 of these immunosuppressed patients is not well known. |
T25 | 2090-2116 | Sentence | denotes | What are the new findings? |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-8 | SP_7 | denotes | COVID-19 |
T2 | 38-43 | UBERON:0002107 | denotes | liver |
T3 | 105-117 | SP_7 | denotes | severe acute |
T4 | 118-129 | SP_7;UBERON:0001004 | denotes | respiratory |
T5 | 130-152 | SP_7 | denotes | syndrome coronavirus 2 |
T6 | 154-164 | SP_7 | denotes | SARS-CoV-2 |
T7 | 179-184 | UBERON:0002107 | denotes | liver |
T8 | 401-406 | UBERON:0002107 | denotes | liver |
T9 | 434-444 | SP_7 | denotes | SARS-CoV-2 |
T10 | 529-534 | UBERON:0002107 | denotes | liver |
T11 | 562-572 | SP_7 | denotes | SARS-CoV-2 |
T12 | 647-655 | SP_7 | denotes | COVID-19 |
T13 | 729-746 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T14 | 928-942 | UBERON:0004535 | denotes | cardiovascular |
T15 | 952-960 | UBERON:0001637 | denotes | arterial |
T16 | 1054-1059 | UBERON:0002048 | denotes | cough |
T17 | 1337-1348 | UBERON:0001004 | denotes | respiratory |
T18 | 1544-1548 | GO:0016265 | denotes | died |
T19 | 1636-1641 | UBERON:0002107 | denotes | liver |
T20 | 1665-1673 | SP_7 | denotes | COVID-19 |
T21 | 1956-1961 | UBERON:0002107 | denotes | liver |
T22 | 1999-2009 | SP_7 | denotes | SARS-CoV-2 |
T23 | 2026-2034 | SP_7 | denotes | COVID-19 |
T24 | 2044-2060 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressed |
T25 | 2143-2148 | UBERON:0002107 | denotes | liver |
T77130 | 0-8 | SP_7 | denotes | COVID-19 |
T67191 | 38-43 | UBERON:0002107 | denotes | liver |
T37655 | 105-117 | SP_7 | denotes | severe acute |
T28710 | 118-129 | SP_7;UBERON:0001004 | denotes | respiratory |
T24293 | 130-152 | SP_7 | denotes | syndrome coronavirus 2 |
T12225 | 154-164 | SP_7 | denotes | SARS-CoV-2 |
T11671 | 179-184 | UBERON:0002107 | denotes | liver |
T23346 | 401-406 | UBERON:0002107 | denotes | liver |
T7088 | 434-444 | SP_7 | denotes | SARS-CoV-2 |
T22469 | 529-534 | UBERON:0002107 | denotes | liver |
T54619 | 562-572 | SP_7 | denotes | SARS-CoV-2 |
T87213 | 647-655 | SP_7 | denotes | COVID-19 |
T97636 | 729-746 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressive |
T83298 | 928-942 | UBERON:0004535 | denotes | cardiovascular |
T78892 | 952-960 | UBERON:0001637 | denotes | arterial |
T26763 | 1054-1059 | UBERON:0002048 | denotes | cough |
T87463 | 1337-1348 | UBERON:0001004 | denotes | respiratory |
T78449 | 1544-1548 | GO:0016265 | denotes | died |
T11406 | 1636-1641 | UBERON:0002107 | denotes | liver |
T46734 | 1665-1673 | SP_7 | denotes | COVID-19 |
T42588 | 1956-1961 | UBERON:0002107 | denotes | liver |
T2254 | 1999-2009 | SP_7 | denotes | SARS-CoV-2 |
T51270 | 2026-2034 | SP_7 | denotes | COVID-19 |
T23921 | 2044-2060 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressed |
T12408 | 2143-2148 | UBERON:0002107 | denotes | liver |